מחלת גרייבס II: פתופיזיולוגיה

In Graves' disease, thyroid-stimulating immunoglobulins (TSI) are autoantibodies produced when immune tolerance fails. These antibodies bind to TSH receptors on thyroid follicular cells and mimic thyroid-stimulating hormone, continuously overstimulating the receptors. This bypasses normal feedback control, causing excessive production and release of T4 and T3 without regulation.

Thyroid follicular cells become tall and columnar, increase in number, and crowd together. Vascularity increases significantly throughout the gland. Colloid stores are rapidly depleted due to excessive hormone utilization, leaving characteristic wavy or scalloped edges on the follicles.

The same autoimmune response targeting thyroid cells also affects fibroblasts expressing TSH receptors in the orbit. Glycosaminoglycan deposition in orbital fibroblasts causes edema and tissue swelling, leading to periorbital edema and exophthalmos, or eye protrusion. This extrathyroidal manifestation occurs independently of thyroid hormone levels.

Pretibial myxedema is thickened, swollen skin patches appearing on the shins. It develops when the autoimmune response targets TSH receptors on skin fibroblasts, particularly in the pretibial region. Glycosaminoglycan accumulation in these fibroblasts causes localized edema and tissue thickening characteristic of this condition.

Excess T4 and T3 in the blood increase basal metabolic rate and heat production. Elevated thyroid hormones also increase sensitivity to catecholamines, raising heart rate and cardiac output. This hypermetabolic state produces tachycardia, palpitations, heat intolerance, and increased sweating as patients struggle to dissipate excess metabolic heat.

Although elevated T3 and T4 normally suppress pituitary TSH through negative feedback, this regulatory mechanism fails in Graves' disease. Antibody-mediated stimulation of TSH receptors persists independently of TSH levels, continuously driving thyroid hormone synthesis. The immune attack bypasses the normal hypothalamic-pituitary-thyroid axis control.

The hypermetabolic state produces weight loss despite increased appetite, fine tremors, anxiety, and hyperactivity. Patients experience tachycardia, palpitations, muscle weakness, and heat intolerance with excessive sweating. In severe cases, arrhythmias or thyroid storm may develop, representing life-threatening complications of uncontrolled hyperthyroidism.